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Abstract
Background: More than a quarter of randomized controlled trials (RCTs) are prematurely discontinued, mostly due
to poor recruitment of patients. In this study, we systematically compared RCTs discontinued or revised for poor
recruitment and completed RCTs with the same underlying research question to better understand the causes of
poor recruitment, particularly related to methodological aspects and context-specific study settings.
Methods: We compared RCTs that were discontinued or revised for poor recruitment to RCTs that were completed
as planned, matching in terms of population and intervention. Based on an existing sample of RCTs discontinued or
revised due to poor recruitment, we identified matching RCTs through a literature search for systematic reviews
that cited the discontinued or revised RCT and matching completed RCTs without poor recruitment. Based on
extracted data, we explored differences in the design, conduct, and study settings between RCTs with and without
poor recruitment, separately for each research question using semi-structured discussions.
Results: We identified 15 separate research questions with a total of 29 RCTs discontinued or revised for poor
recruitment and 48 RCTs completed as planned. Prominent research areas in the sample were cancer and acute
care. The mean number of RCTs with poor recruitment per research question was 1.9 ranging from 1 to 4
suggesting clusters of research questions or settings prone to recruitment problems. The reporting quality of the
recruitment process in RCT publications was generally low. We found that RCTs with poor recruitment often had
narrower eligibility criteria, were investigator- rather than industry-sponsored, were associated with a higher burden
for patients and recruiters, sometimes used outdated control interventions, and were often launched later in time
than RCTs without poor recruitment compromising uncertainty about tested interventions through emerging
evidence. Whether a multi- or single-center setting was advantageous for patient recruitment seemed to depend
on the research context.
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Conclusions: Our study confirmed previously identified causes for poor recruitment, i.e., narrow eligibility criteria,
investigator sponsorship, and a reduced motivation of patients and recruiters. Newly identified aspects were that
researchers need to be aware of all other RCTs on a research question so that compromising effects on the
recruitment can be minimized and that a larger number of centers is not always advantageous.
Keywords: randomized controlled trials , early termination of clinical trials, poor recruitment, systematic reviews,
qualitative analysis
Background
Evidence-based health care relies on high-quality clinical
research. Randomized controlled trials (RCTs) are the
method of choice to assess preventive and therapeutic
interventions and are a cornerstone in the final phase of
drug development and in comparative effectiveness re-
search. Conducting high-quality RCTs, however, is chal-
lenging. More than a quarter of RCTs do not reach the
planned sample size, mostly due to poor recruitment of
patients, and are prematurely discontinued [1, 2].
Investigator-initiated RCTs are particularly prone [1].
Implications of poor patient recruitment and premature
discontinuation of RCTs are that up to 70% of such tri-
als remain unpublished, root causes of recruitment diffi-
culties are not shared with the scientific community and
may therefore be repeated in the future, research ques-
tions remain unanswered, and substantial amounts of
scarce research resources are wasted [1, 3].
To better understand the causes of poor recruitment,
previous quantitative approaches using RCT protocols
and registry information [1, 2] as well as qualitative ana-
lyses from published reports and semi-structured inter-
views with trialists and other stakeholders in clinical
research have already provided important insights [3, 4].
That is, for instance, that investigator-initiated RCTs or
RCTs in the acute care setting were found to be at much
higher risk for discontinuation due to poor recruitment
than industry-sponsored RCTs or RCTs in non-acute
care settings [1, 2]; or that insufficient preparation,
overly narrow eligibility criteria, and prejudiced views of
recruiters and patients on trial interventions are com-
mon reasons for poor recruitment [3]. As suggested by
others previously [5], we undertook a systematic com-
parison of RCTs discontinued or revised for poor re-
cruitment and RCTs completed as planned with the
same underlying research question. We aimed to provide
additional evidence on potential causes for poor recruit-
ment specifically related to design aspects and context-
specific study settings of RCTs.
Methods
This is a matched qualitative study comparing RCTs that
did not reach 90% of their originally planned sample size
due to poor recruitment (cases; discontinued or revised
RCTs with poor recruitment) to RCTs completed as
planned (controls without poor recruitment) matching
in terms of patient population and experimental inter-
vention. The study is reported according to the Stan-
dards for Reporting Qualitative Research (SRQR, http://
www.equator-network.org/reporting-guidelines/srqr/) as
described in Additional file 1.
Identification of discontinued and matching completed
RCTs
In a previous study, we included 20 RCTs that were dis-
continued or revised for poor recruitment with the
planned sample size being reported in a publication [1].
For these studies, we aimed to find matching RCTs
reaching at least 90% of their originally planned sample
size. We searched for systematic reviews that cited the
discontinued or revised RCT using the “times cited”
function in Web of Science (times cited “view all of the
articles that cite this one” https://apps.webofknowledge.
com) in January 2016. One reviewer (VG) screened the
titles, abstracts, and full texts of potentially eligible sys-
tematic reviews for relevance. An eligible systematic re-
view had to describe a literature search conducted in at
least one electronic database (e.g., Medline), include
RCTs, and had to have a research question similar to
that of the discontinued or revised RCT. If more than
one systematic review were eligible, we chose the most
up-to-date, comprehensive systematic review (frequently
a Cochrane review). If no systematic review was identi-
fied, we searched by the same means for similar narra-
tive reviews. In case VG was in doubt about the
eligibility of a systematic review, she involved a second
reviewer (MB) for discussion and consensus decision.
From each eligible systematic review we retrieved the
full text articles of included RCTs (i.e., potentially eli-
gible matching RCTs) and collected a small set of pre-
liminary data. These included whether the RCT was
discontinued or revised for poor recruitment, planned
and actually achieved sample size, the patient popula-
tion, and the experimental and control intervention.
This was done by two methodologically trained investi-
gators (VG, BS) working independently and in duplicate.
Any disagreements were resolved by consensus and, if
needed, through involving another investigator (MB).
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The matching criteria (inclusion criteria) were the tested
intervention and included patient population, which
needed to be similar enough so that the RCTs could be
included in the same meta-analysis. Other trial charac-
teristics such as comparator interventions, outcomes of
interest, and trial settings already qualified as factors po-
tentially associated with poor recruitment.
Data collection
The following data were collected from the eventually in-
cluded RCTs: study design (e.g., superiority or non-
inferiority trial, factorial or parallel design, allocation ratio),
sample size calculation, allocation concealment, blinding,
reporting quality of the recruitment process, eligibility cri-
teria, trial sponsor, country and place of patient recruitment,
recruitment period, reporting of recruitment networks, sup-
port from a clinical trial unit or contract research
organization, study population, interventions, comparators,
and primary outcome. In addition, we also extracted self-
reported reasons (if any) for poor recruitment of the
discontinued or revised RCTs. Data were collected by one in-
vestigator (VG or BS) and checked by another (VG, BS or
MB). Any disagreements were resolved by consensus.
Data analysis
We explored differences in the design, conduct. and study
settings between RCTs with and without poor recruit-
ment, separately for each research question, thus context-
specific, using semi-structured discussions (MB, BS, and
VG). In a first round, we gathered differences between
RCTs with and without poor recruitment, based on our
extracted data; we systematically went through a pre-
specified checklist of items potentially associated with
poor recruitment, including eligibility criteria, trial spon-
sor, single versus multiple centers, etc. (Additional file 2);
and discussed each item in turn followed by observations
beyond the checklist items (e.g., the chronology of RCTs
building up the evidence base for a specific research ques-
tion). When we reached agreement among us, the identi-
fied differences and potentially relevant observations were
captured by VG in free-text form. In a second round, we
reflected on the identified differences between RCTs with
and without poor recruitment and other relevant observa-
tions for each research question and integrated the rele-
vant information in order to come up with an explanation
why for a certain research question one or more RCTs
had serious recruitment problems while others did not
have such problems. In addition, we considered the self-
reported reasons for poor recruitment (if any).
Researchers’ reflexivity
The three researchers who carried out the analysis have di-
verse disciplinary background and training such as medicine/
clinical epidemiology (MB), nutrition/health technology
assessment (VG), and epidemiology/public health (BS). To
better understand specific characteristics of oncology trials,
we involved a practicing oncologist in the respective discus-
sions. For the other topics, the analysis team members felt
that they had sufficient knowledge to assess trial characteris-
tics, and their methodological expertise with clinical trials
likely strengthened the analysis. None of us knew any of the
included RCTs or their investigators. During analysis, all re-
searchers worked together as a team and extensively dis-
cussed the data interpretation to minimize bias.
Results
Study sample
In a previous study, there were 20 published RCTs discon-
tinued or revised for poor recruitment that reported the
planned sample size [1]. For five of these RCTs our litera-
ture search could not identify a systematic or narrative re-
view that cited the discontinued or revised RCT (Fig. 1).
For the remaining 15 RCTs discontinued or revised due to
poor recruitment representing 15 different research ques-
tions, we identified 110 matching RCTs. We excluded 48
RCTs because the planned sample size was not reported
(n = 31); the RCT was discontinued for another reason
than poor recruitment (n = 9); the article was not pub-
lished in English (n = 3); the research question was not
similar enough (n = 2); there was no full-text publication
available (n = 2); or the same results were published mul-
tiple times (n = 1). Of the 62 matching RCTs, 48 were
completed as planned and 14 were newly identified RCTs
discontinued or revised for poor recruitment. Hence, for
15 separate research questions a total of 77 RCTs (29 with
and 48 without poor recruitment) were available for com-
parative analyses. Twenty-five of the 29 RCTs with poor
recruitment explicitly reported that they were discontin-
ued due to recruitment problems; the remaining four
RCTs [6–9] had recruitment problems but revised their
original target sample sizes during the trial (reduction of
the originally planned number of patients in each trial by
about 50%) and met the revised targets. References of all
included RCTs are provided in Additional file 3.
Research questions, recruitment, and reporting quality
Medical areas of the 15 included research questions were
cancer research (n = 5), research in acute care (n = 8; in-
cluding preterm infants [n = 2] and laboring women [n =
1]), surgery (n = 1), and infectious diseases (n = 1). The
mean number of RCTs with poor recruitment was 1.9 per
research question ranging from 1 to 4. Table 1 summa-
rizes the recruitment characteristics for the RCTs with
and without poor recruitment across all research ques-
tions. In general, RCTs with poor recruitment recruited
fewer patients per year per recruiting center compared to
RCTs that were completed as planned. More detailed re-
cruitment characteristics for each research question and
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for all included RCTs, as well as general study characteris-
tics are provided in Additional files 4, 5 and 6.
The reporting of the recruitment process was generally
in included RCT publications with little detail. None of
the articles reported on who actually recruited patients
or the anticipated prevalence of eligible patients. Only
6% (5/77) of the RCTs reported on the anticipated re-
cruitment duration, 51% (39/77) reported the location
where patients were recruited, 27% (21/77) provided a
detailed patient flow, and 90% (69/77) reported the ac-
tual recruitment period or duration (Additional file 7).
Comparison of RCTs with and without poor recruitment
Table 2 summarizes the differences observed between
RCTs with and without poor recruitment for each research
question as well as our context-specific conclusions on the
possible reasons for poor recruitment. The most recurrent
theme across research questions was that, in RCTs with
poor recruitment, eligibility criteria were substantially nar-
rower than in RCTs without poor recruitment (research
questions #1, #2, #3, #4, #9, #12, #13 in Table 2).
There was no consistent pattern as to whether an
international or national multicenter setting or a single-
Fig. 1 Selection of included randomized controlled trials. *Five of the original 20 discontinued RCTs for poor recruitment that were published
and reported a sample size calculation were excluded, because we did not identify a systematic review or narrative review citing the RCT.
**Including four RCTs with recruitment problems but revised original target sample sizes during the trial (reduction of the originally planned
number of patients in each trial by about 50%) and meeting their revised targets. RCT randomized controlled trial
Table 1 Recruitment characteristics of included randomized controlled trials with and without poor recruitment across research
questions
RCTs with poor recruitment, n = 29 RCTs without poor
recruitment, n = 48
Originally planned number of patients (median; IQR) 395 (72–600) 272 (22–500)
Number of patients randomized (median; IQR) 150 (41–329) 306 (23–559)
Duration of recruitment period in months (median; IQR) 39 (10–47) 24 (7–45)
Number of patients recruited per year and centera (median; IQR) 3 (1–5) 7 (1–25)
Trial sponsor (industry n (%) / investigator n (%)) 12 (41%) / 17 (59%) 20 (42%) / 27 (56%) /
NR 1 (2%)
IQR interquartile range (25th and 75th percentile), NR not reported, RCT randomized controlled trial
aRough estimate for recruitment speed based on own calculations (number of patients recruited divided by recruitment duration and number of study centers);
not adjusted to the time a site was actually open for recruitment, because this was not reported in the publications of included trials)
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center setting was advantageous for patient recruitment
in RCTs. In research question #4, for instance, investi-
gating antiarrhythmic drugs, the RCT with poor recruit-
ment had three to four times fewer study centers than
RCTs without poor recruitment; or in research area #2
(metastatic breast cancer therapy) the RCTs with poor
recruitment were all restricted to a national setting,
while the RCTs without poor recruitment were all done
in large international collaborations. On the other hand,
single-center RCTs or settings with only a few, carefully
chosen study centers may have worked better in settings
with particular logistical challenges (e.g., question #8 on
primary angioplasty versus onsite thrombolysis and
question #15 testing therapies for resuscitation) or the
inclusion of particularly vulnerable patients (e.g., re-
search questions #6 and #7 focusing on the recruitment
of preterm neonates) in the absence of well-established
and experienced trial networks.
We observed that investigator-sponsored RCTs are as-
sociated with a higher risk for poor recruitment than
industry-sponsored RCTs; in research questions #1 and
#12 all RCTs with poor recruitment were investigator-
sponsored, while all RCTs without poor recruitment
were industry-sponsored.
The chronology of RCTs, e.g., when a RCT is launched
while other RCTs on the same research question have
already been completed, appears to impact on recruit-
ment. RCTs with poor recruitment were often initiated
and published later, after other RCTs had already been
successfully completed (research questions #2, #6, #10,
#13, #14); i.e., evidence on the potential benefits and
harms of a certain intervention was already available at
some point during the conduct of such RCTs. This may
have compromised the uncertainty about the tested
treatments as an ethical precondition (equipoise), and
the motivation of patients and recruiters for further
randomization. In research questions #10 and #11 the
control intervention(s) were already outdated, when the
RCTs with poor recruitment were launched. In addition,
in some RCTs with poor recruitment the burden for pa-
tients, such as numerous or invasive assessments during
follow-up (research questions #1, #12, #14), or the burden
for recruiters, such as the need to apply a complex scoring
system in order to include patients (research question #9),
was higher than in corresponding RCTs without poor re-
cruitment. Furthermore, it happened that the tested inter-
ventions (already available drugs in RCTs with poor
recruitment versus new drugs in RCTs without poor re-
cruitment; research question #4) or the study design with
side effects of the experimental drug being the primary
outcome (research question #6) were less attractive in
RCTs with poor recruitment than in corresponding RCTs
without poor recruitment. If interventions to be compared
in an RCT not only differed in the administered substance
or drug but, in addition, in the route (e.g., intravenous or
oral administration) or timing of application, then pa-
tients’ preferences could have compromised their willing-
ness to be randomized (research question #11 in Table 2).
Discussion
Main findings
In this qualitative comparison between RCTs that did
not achieve their originally planned sample size due to
recruitment problems and RCTs that were completed as
planned, we identified several reasons for poor recruit-
ment. We found that RCTs with poor recruitment often
had narrower eligibility criteria than RCTs without poor
recruitment, were investigator-sponsored rather than
industry-sponsored, and were less attractive for patients
and recruiters due to higher burden, outdated control
interventions, or already existing or accumulating evi-
dence on benefits and harms of interventions from other
RCTs. An existing network of study centers experienced
in the conduct of RCTs is instrumental for successful re-
cruitment, but whether one or a few study centers or an
international multicenter design was more advantageous
seemed to depend on the research context. With chal-
lenging settings such as acute care, vulnerable patients,
or complex logistics, one or a few carefully chosen cen-
ters may be preferable due to closer monitoring of re-
cruitment, potentially better prepared and motivated
study staff, established procedures and, perhaps most
important, efficient communication among the trial
team. Prominent research areas in our sample were can-
cer research and research in acute care with, on average,
more than one RCT with poor recruitment per research
question suggesting that there are clusters of research
areas typically prone to recruitment problems.
Strengths and limitations
The strengths of our study include a new systematic ap-
proach to qualitatively compare RCTs discontinued or
revised due to poor recruitment and RCTs completed as
planned, that had previously been suggested [5] but, to
our knowledge, never been used to date. We included 77
RCTs from a broad range of settings and research topics
and analyzed them specifically in their context, thereby
strengthening the applicability of our results.
Our study has several limitations. First, the present
qualitative analysis was limited to the information pro-
vided in publications of RCTs and did not include infor-
mation from other sources such as study protocols or
interviews with trialists. This might have constituted a se-
lection because the majority of RCTs discontinued for
poor recruitment were not published in a peer-reviewed
journal [1]. Second, we were not able to assess reasons for
poor recruitment that were not described (e.g., lack of
funding, a theme recurrently coming up in an interview
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study on the topic [4]). Third, we did not comprehensively
search the literature for reports of RCTs discontinued or
revised due to poor recruitment, but pragmatically started
out with a sample of discontinued or revised RCTs identi-
fied in a previous study [1], and we used existing system-
atic and narrative reviews to find matching RCTs. In
addition, we excluded 31 RCTs from our analysis because
articles did not report a planned sample size, and there-
fore we were unable to judge whether the originally
planned sample size was achieved or not. Fourth, the
reporting of the patient recruitment process in included
RCT publications provided little detail (irrespective of
whether the RCT struggled with recruitment or not) com-
promising the effectiveness of our qualitative analysis. Par-
ticularly the fact that many articles did not report the
number of patients screened for eligibility, the number
not meeting eligibility criteria, and the number of patients
declining to participate, often limited a better understand-
ing of potential recruitment problems. Fifth, one re-
searcher extracted all relevant information from included
RCT publications and another checked this information
rather than two researchers extracting relevant data inde-
pendently and in duplicate. We chose this approach for
feasibility reasons risking a higher rate of extraction errors.
However, information directly relevant for our interpret-
ation of reasons underlying recruitment problems were ac-
tually verified by two methodologically trained researchers.
Sixth, although our study captured a broad range of clinical
areas, 12 of the 15 research questions were related to drug
therapy, leaving uncertainty whether our findings are
equally applicable to other interventions such as surgery,
behavior change, or complex interventions. Finally, al-
though we found evidence for saturation in our qualitative
analysis, the size of our study sample was mainly deter-
mined by practical issues of our approach.
Comparison with other studies investigating poor
recruitment in RCTs
Our results confirm several findings of previous studies
using different methods. Investigator-sponsored (in the
sense of investigator-initiated) RCTs, for instance, were
found to be at higher risk for discontinuation due to
poor recruitment than industry-sponsored RCTs by two
studies using a quantitative approach with multivariable
regression analysis [1, 2]. The common interpretation is
that industry sponsorship is associated with sufficient
funding and better planning and conduct, factors that fa-
cilitate successful patient recruitment. Moreover, the
acute care setting (e.g., emergency rooms, intensive care
units, care for preterm neonates) seems particularly
prone to insufficient recruitment [10].
Similar to the present study, a systematic review of
published reports of RCTs discontinued due to poor re-
cruitment found that overly narrow eligibility criteria
and prejudiced views of recruiters and patients on trial
interventions were the most frequent reasons for poor
recruitment [3]. Prejudiced views of patients and re-
cruiters may come from different sources. Our study
found that RCTs with poor recruitment were often
launched relatively late in the sequence of RCTs on the
same research question. As evidence accumulates over
time, the uncertainty about the benefits and harms of a
certain intervention or about the superiority of one
intervention over another (equipoise) may become in-
creasingly compromised. Some control interventions
were even considered outdated right from the start of an
RCT (research questions #10 and #11 in Table 2), which
confirms the observation by Habre et al. [11]. In some
instances, the route of application of an intervention or
the more complex logistics associated with an interven-
tion were less appealing to patients or recruiters. This is
also consistent with the finding by Bernardez-Pereira
et al. that single-arm clinical trials were less prone to
discontinuation due to poor recruitment compared to
multiple-arm trials. That is because in single-arm trials
all patients receive the same intervention and, thus, are
not confronted with the fact that they could be random-
ized to a different, maybe less preferred, treatment [2].
Another common finding in RCTs with poor recruit-
ment was a high burden or inconvenience for patients or
recruiters due to trial procedures (e.g., many follow-up
visits, blood draws, lengthy questionnaires or case report
forms). This was mentioned previously as a problem in
several other qualitative studies [3, 12–14].
Our study highlights two aspects about recruitment
challenges to RCTs that are, so far, not prominent in the
published literature. First, investigators need to be aware
of all other RCTs on a research question, their timing,
and the accumulating evidence base, so that potentially
compromising effects on the recruitment to their own
trial can be minimized. Second, apart from the notion
that well-established networks of collaborating study
centers are an asset for the successful recruitment of pa-
tients to RCTs [4], it seems that a larger number of cen-
ters is not always advantageous. The performance of a
study center typically depends on its commitment to-
ward an RCT, the enthusiasm, training, and quality of
communication of staff; therefore, challenging settings
such as acute care, vulnerable patients, or complex logis-
tics require careful selection and close monitoring of
participating centers.
Finally, our study documents the urgent need for a more
detailed reporting of participant recruitment in RCTs, which
is in line with previous reports [3, 15, 16]. Furthermore, we
did not find that poor reporting of the recruitment process
was a particular issue of RCTs discontinued or revised for
poor recruitment. Indicating that, if they do indeed get pub-
lished, the reporting quality of the recruitment process is
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similarly poor as in RCTs that were completed as planned.
The current Consolidated Standards of Reporting Trials
(CONSORT) statement [17] explicitly recommends report-
ing the number of patients assessed for eligibility, number of
eligible patients, and number of consenting patients. In the
context of RCT discontinuation due to poor recruitment,
however, investigators should additionally describe how they
projected the number of eligible and consenting patients;
whether a pilot study including informed consent was done;
whether recruitment was closely monitored; which measures
were undertaken to improve recruitment; and the specific
root causes for recruitment failure in their case, so that fu-
ture recruitment failures in that area of research can effi-
ciently be prevented.
Given its magnitude and global presence of the problem,
the evidence base on what actually works to improve re-
cruitment in RCTs is still astonishingly thin [18, 19]. Based
on the numerous analyses about the nature, extent, and
causes for recruitment failure, it is time for international
collaborative efforts to overcome the problem. Specifically,
we need more randomized ‘studies within a trial’ (SWATs),
i.e., promising interventions to improve recruitment need
to be empirically evaluated within a host trial as propagated
by the Trial Forge initiative, the Medical Research Council’s
Network of Hubs for Trials Methodology Research in the
UK, and the Health Research Board’s Trials Methodology
Research Network in Ireland [20, 21].
Conclusions
This qualitative comparison of RCTs discontinued or re-
vised due to poor recruitment and RCTs completed as
planned on the same research question complements
previous efforts to identify risk factors for recruitment
failure in RCTs, and to better understand the underlying
mechanisms. Our study confirms previously identified
causes such as narrow eligibility criteria, investigator-
sponsorship, and a high burden of trial procedures for
patients and recruiters, but also stresses the importance
of considering the accumulating evidence and the timing
of other RCTs on the same topic as well as carefully
selecting and closely monitoring participating centers for
RCTs in challenging settings. A more detailed reporting
of patient recruitment in RCTs is urgently needed so
that recruitment failure can provide lessons for other re-
searchers in the future.
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